Medtronic says it agreed to the terms of a consent decree with the FDA over its SynchroMed drug-infusion pump and its neuromodulation quality system.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1JvBmzs
Cap comentari:
Publica un comentari a l'entrada